The American Society of Hematology Honors Ayalew Tefferi, MD, with the 2016 Henry M. Stratton Medal

[Fishermangents]

Published on: August 04, 2016

(WASHINGTON, August 4, 2016) The American Society of Hematology (ASH) will recognize J. Evan Sadler, MD, PhD, of Washington University School of Medicine in St. Louis, and Ayalew Tefferi, MD, of Mayo Clinic College of Medicine, with the 2016 Henry M. Stratton Medal for their seminal contributions in the areas of basic and clinical/translational hematology research, respectively.

The Henry M. Stratton Medal is named after the late Henry Maurice Stratton, co-founder of Grune and Stratton, the medical publishing house that first published ASH’s journal Blood. The prize honors two senior investigators whose contributions to both basic and clinical/translational hematology research are well recognized and have taken place over a period of several years. Drs. Sadler and Tefferi will accept their awards at 9:30 a.m. on Tuesday, December 6, during the 58th ASH Annual Meeting and Exposition in San Diego.
../..
Dr. Tefferi, the recipient of the 2016 Henry M. Stratton Medal for Clinical/Translational Science, is a Professor of Medicine at Mayo Clinic College of Medicine in Rochester, Minnesota. He has devoted his career to the study of myeloproliferative neoplasms (MPNs) and other myeloid malignancies. He has been instrumental in establishing the myeloproliferative practice at the Mayo Clinic, where he trained young staff to help conduct translational and clinical research. Dr. Tefferi is best known for his groundbreaking work in defining the pathogenesis and prognostic features of myeloproliferative neoplasms, as well as testing novel treatments. He has been a leader in the discovery and characterization of pathogenic mutations in MPNs and their rapid translation into disease classification, prognostication, and treatment, which has led to his clinical trial work using JAK inhibitors in patients. Dr. Tefferi has also served on the World Health Organization classification committee for myeloid neoplasms and has led the effort in revising the diagnostic criteria for MPNs. His expertise in the field and superior lectures are well recognized, and he has been a key faculty member of many national board review courses, including those sponsored by Harvard Medical School, The University of Texas MD Anderson Cancer Center, and George Washington University.

After earning his medical degree from the University of Athens Medical School in Athens, Greece, in 1982, Dr. Tefferi completed a residency in internal medicine at St. Joseph Hospital in Chicago, Illinois. He went on to complete his fellowship at Mayo Clinic College of Medicine in 1989, and later joined the institution’s faculty.

Dr. Tefferi is a member of many societies, including ASH. He has also served on the editorial board of several journals, including Blood, the Journal of Clinical Oncology, Leukemia, the American Journal of Hematology, and the Mayo Clinic Proceedings. He is currently the editor-in-chief of the Blood Cancer Journal. Dr. Tefferi has published over 580 peer reviewed articles, and he is currently a physician author for the MPN content in UpToDate. In 2008, The University of Texas MD Anderson Cancer Center awarded Dr. Tefferi the Emil J. Freireich Medal, their highest award for achievement in the management of cancer. He has been rated “Best Teacher” by medical students at Mayo Clinic multiple times.

link: http://www.hematology.org/Newsroom/Pres ... /6502.aspx

=======

Imetelstat is in good hands....